Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 565-576 of 10,612

Behavioral study icon

RecruitingNCT05918835

Effects of rTMS on Food Choice in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralFrom 18 Years to 35 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Eating disorders

Other study type icon

RecruitingNCT06936202

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionOtherFrom 16 Years to 65 Years

Countries: United States
Sponsor: Arizona State University
Condition: Depression

Device study icon

RecruitingNCT07203092

Effects of Transcranial Photobiomodulation in ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDeviceFrom 18 Years to 44 Years

Countries: United States
Sponsor: Francisco Gonzalez-Lima, PhD
Condition: ADHD

Behavioral study icon

RecruitingNCT06365723

Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Crossover study

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AnxietyBehavioralFrom 25 Years to 64 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Anxiety

Other study type icon

RecruitingNCT06714942

Proprietary Blend of Ashwagandha Root Extract (Aqueous) for anxiety

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AnxietyOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: SF Research Institute, Inc.
Condition: Anxiety

Drug study icon

RecruitingNCT03817502

Cariprazine for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Colombia, ...

Location not clearly listed

SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Bulgaria, Colombia, ...
Sponsor: Gedeon Richter Plc.
Condition: Schizophrenia

Drug study icon

RecruitingNCT05837104

Magnesium Vitamin B6 for Bipolarity

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

Bipolarity, Depression, ...DrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Bipolarity, Depression, ...

Drug study icon

RecruitingNCT06847399

Tirzepatide for Eating disorders

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

Eating disordersDrugOver 18 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Eating disorders

Behavioral study icon

RecruitingNCT05541406

Efficacy of a Multi-level School Intervention for LGBTQ Youth

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Suicidality, PTSD, ...BehavioralFrom 12 Years to 20 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: Suicidality, PTSD, ...

Drug study icon

RecruitingNCT05011266

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Behavioral study icon

RecruitingNCT07299474

Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyBehavioralOver 18 Years

Countries: United States
Sponsor: Cedars-Sinai Medical Center
Condition: Anxiety

Drug study icon

RecruitingNCT07227818

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.